What Is Coronary Calcium Score

A coronary calcium score is a numerical value derived from a non-contrast cardiac CT scan that quantifies the amount of calcified plaque in the coronary arteries. The result, known as the Agatston score, reflects the cumulative burden of atherosclerosis and serves as an independent predictor of heart attack and cardiovascular death. Because atherosclerosis can develop silently for decades, this test provides a direct anatomical snapshot of disease that blood tests and risk calculators alone cannot offer.

Cardiovascular disease remains the leading cause of death globally, and a significant portion of heart attacks occur in people who had no prior symptoms and whose standard risk factors appeared only moderately elevated. Traditional risk assessment relies on indirect markers such as cholesterol levels, blood pressure, and family history, which are combined into statistical models that estimate probability. These models are useful at a population level but can misclassify individual risk in either direction.

The coronary calcium score addresses this gap by providing direct evidence of whether atherosclerosis is already present in the arterial wall. For longevity planning, this distinction matters enormously. An individual with a zero score has a meaningfully different risk trajectory than someone with a score of 200, even if their cholesterol panels look identical. This information can sharpen decisions about statin therapy, lifestyle intensity, and the urgency of further cardiac evaluation. In the context of healthspan, catching and responding to subclinical coronary disease years before a clinical event is one of the highest-leverage screening opportunities available.

During a coronary artery calcium (CAC) scan, the patient lies in a CT scanner while electrocardiogram leads synchronize image acquisition with the heartbeat. The scanner captures thin cross-sectional images of the heart in a few seconds, during a single breath hold. No contrast dye is injected. The entire procedure typically takes under ten minutes, with actual scanning time under one minute.

The images are then analyzed to identify areas of high density within the coronary arteries, which correspond to calcium deposits. Each calcified lesion is scored based on its area and peak density using the Agatston method, and all lesion scores are summed to produce the total coronary artery calcium score. A score of zero means no calcified plaque was detected. Scores between 1 and 99 indicate mild plaque, 100 to 399 moderate plaque, and 400 or above extensive calcified atherosclerosis. Percentile rankings adjusted for age, sex, and ethnicity add further context, because a score of 50 carries different implications for a 45-year-old than for a 75-year-old.

The biological basis is straightforward: as atherosclerotic plaque matures within artery walls, smooth muscle cells and macrophages deposit hydroxyapatite crystite, the same mineral found in bone. This calcification process is part of the body's attempt to stabilize plaques. The calcium detected on CT therefore represents a subset of total plaque burden, specifically the older, more mineralized lesions. Soft, lipid-rich plaque that has not yet calcified will not register on this scan, which is why a zero score reduces but does not eliminate cardiovascular risk.

The coronary calcium score measures the total volume and density of calcium deposits within the walls of the coronary arteries. These deposits are composed of hydroxyapatite, the same mineral found in bone, and they accumulate as atherosclerotic plaques mature over years to decades. The Agatston scoring method assigns a weighted value to each calcified lesion based on its area (in square millimeters) and its peak CT attenuation (a measure of density), then sums all lesions across the left main, left anterior descending, circumflex, and right coronary arteries.

What the test fundamentally captures is a proxy for cumulative lifetime atherosclerotic burden. It does not measure soft or fibrous plaque, and it cannot determine whether a particular lesion is flow-limiting. However, because calcified plaque correlates strongly with total plaque volume in population studies, the score serves as a reliable indicator of the overall disease state of the coronary vasculature.

Preparation for a coronary calcium scan is minimal. No fasting is required, and no intravenous contrast dye is used. Patients should avoid caffeine for several hours before the scan if possible, as caffeine can increase heart rate, which may reduce image quality. Wearing comfortable clothing without metal snaps or underwire near the chest simplifies the process, though a gown is typically provided.

The scan itself requires lying flat and holding still for approximately five to ten seconds during image acquisition. Electrocardiogram leads are placed on the chest to synchronize image capture with the cardiac cycle. The entire visit, from arrival to departure, usually lasts under thirty minutes. No sedation or recovery time is needed.

Results are reported as a single Agatston score. A score of zero indicates no detectable calcified plaque and is associated with a very low short-term risk of cardiac events. Scores of 1 to 99 suggest mild atherosclerosis, 100 to 399 moderate disease, and 400 or above extensive calcification. Some reports also provide a percentile rank comparing the patient's score to others of the same age, sex, and ethnicity. Being above the 75th percentile for age indicates disproportionately high plaque burden relative to peers.

The clinical implications depend on context. A moderate score in a 45-year-old is more alarming than the same number in a 70-year-old, because the younger patient has more years of potential plaque progression ahead. In many clinical frameworks, any nonzero score tips the balance toward initiating or intensifying statin therapy, tightening LDL cholesterol targets, and possibly pursuing CT coronary angiography if the score is high. The score does not diagnose a blockage; it quantifies the anatomical footprint of atherosclerosis as a disease process.

For individuals with a baseline score of zero, repeating the scan in five to seven years is a common recommendation, assuming no significant change in risk factors or symptoms. The rationale is that progression from zero to a meaningful score typically takes years, and more frequent scanning adds radiation exposure without changing management.

For those with a nonzero score, some clinicians recommend repeat scanning in three to five years to assess the rate of calcium progression. The annual rate of increase, expressed in Agatston units per year, may offer additional predictive value beyond the baseline score. However, there is no universal consensus on serial scanning intervals, and guidelines from different medical societies vary. The decision to repeat the test should weigh the added information against cumulative radiation exposure and the clinical response already in place.

The coronary artery calcium score has been studied extensively over more than two decades. Large prospective cohort studies, including the Multi-Ethnic Study of Atherosclerosis (MESA), have followed tens of thousands of individuals and consistently shown that the CAC score is an independent predictor of major cardiovascular events, adding prognostic information beyond traditional risk factors. A score of zero has been associated with very low event rates (well under one percent per year in most populations), while scores above 300 to 400 are associated with substantially elevated risk.

Multiple medical societies have endorsed the use of CAC scoring for risk stratification in intermediate-risk adults. The test is particularly valued for its ability to reclassify risk, meaning it changes clinical decision-making in a measurable fraction of patients. However, there are recognized limitations. The scan cannot detect non-calcified (soft) plaque, which can be clinically significant. There is also ongoing debate about optimal intervals for repeat scanning and whether serial CAC scores should guide treatment intensity. Randomized trials specifically testing whether CAC-guided prevention strategies reduce hard clinical endpoints are limited compared to the observational evidence, though several trials have shown that sharing CAC results with patients improves adherence to preventive therapies.

The primary risk is a small dose of ionizing radiation, typically in the range of one millisievert, which is low but not zero. False reassurance from a zero score is a consideration, as non-calcified plaque can still be present and clinically relevant. Elevated scores can provoke anxiety and may lead to additional testing and procedures that carry their own risks and costs. Statin therapy, which may be initiated based on a high score, can itself cause calcification to increase slightly as plaques stabilize, which can be confusing if serial scans are performed without understanding this phenomenon. The test is not recommended for very young, very low-risk individuals or for those who already have established coronary artery disease, where it adds little incremental information.